<DOC>
	<DOCNO>NCT00131144</DOCNO>
	<brief_summary>The common ocular disease patient diabetes , diabetic retinopathy , present approximately 40 % diabetic patient ; 8 % diabetic patient vision threaten diabetic retinopathy . Although intensive control blood glucose show reduce development progression diabetic retinopathy , intensive control glucose usually achieve clinical practice .</brief_summary>
	<brief_title>Octreotide Acetate Microspheres Patients With Diabetic Retinopathy</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<criteria>Males female type 1 type 2 diabetes mellitus Moderately severe severe NPDR mild PDR least one eye : Early Treatment Diabetic Retinopathy Study ( ETDRS ) visual score &gt; 35 letter ; previously treat scatter photocoagulation . HbA1c &lt; 13 % study entry Condition could interfere assessment retinopathy progression History symptomatic gallstone without cholecystectomy Brittle diabetes history severe hypoglycemia unawareness Previous treatment somatostatin analogue</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Diabetic retinopathy , Octreotide Acetate Microspheres</keyword>
</DOC>